Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.

Muzard C, Seguin J, Bonnefoy J, Salkini N, Serra V, Alhareth K, Lemdani K, Mignet N

Open source

DOI
10.1007/s44164-025-00096-5
Published
2025 Oct
Container
In vitro models
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s44164-025-00096-5,
  title = {Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.},
  author = {Muzard C and Seguin J and Bonnefoy J and Salkini N and Serra V and Alhareth K and Lemdani K and Mignet N},
  year = {2025},
  journal = {In vitro models},
  doi = {10.1007/s44164-025-00096-5},
  url = {https://doi.org/10.1007/s44164-025-00096-5}
}

RIS

TY  - JOUR
TI  - Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.
AU  - Muzard C
AU  - Seguin J
AU  - Bonnefoy J
AU  - Salkini N
AU  - Serra V
AU  - Alhareth K
AU  - Lemdani K
AU  - Mignet N
PY  - 2025
JO  - In vitro models
DO  - 10.1007/s44164-025-00096-5
UR  - https://doi.org/10.1007/s44164-025-00096-5
ER  - 

APA

C, M., J, S., J, B., N, S., V, S., K, A., K, L., & N, M. (2025). Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.. In vitro models. https://doi.org/10.1007/s44164-025-00096-5

Source records